期刊文献+

终末期肾病相关性肾细胞癌的研究进展

Research progress of end-stage renal disease complicated with renal cell carcinoma
下载PDF
导出
摘要 控制终末期肾病患病率和病死率的上升是我国慢性病防治的重点。发生终末期肾病相关性肾细胞癌是终末期肾病患者死亡的主要原因。终末期肾病相关性肾细胞癌的病理学类型包括常见的肾细胞癌组织学亚型和独特的组织学亚型,如获得性囊性肾病相关性肾细胞癌和透明细胞乳头状肾细胞癌等,且诊治较为棘手。本文就终末期肾病相关性肾细胞癌的病因、发病率、发病机制、病理分型及预后进行简要综述,有助于提高对终末期肾病相关性肾细胞癌在泌尿系统疾病中的认识。 The increase of the morbidity and mortality of end-stage renal disease is the focus of chronic disease prevention and treatment in China.Renal cell carcinoma associated with end-stage renal disease is the leading cause of death in patients with end-stage renal disease.The pathological types of end-stage renal disease associated renal cell carcinoma include conventional renal cell carcinoma histological subtypes and unique histological subtypes,such as acquired cystic kidney disease associated renal cell carcinoma and clear cell papillary renal cell carcinoma,which are difficult to diagnose and treat.This article reviews the etiology,incidence,pathogenesis,pathological classification,and prognosis of end-stage renal disease associated renal cell carcinoma,which is helpful to improve the understanding of end-stage renal disease associated renal cell carcinoma in urinary diseases.
作者 刘威 喻春钊 杨健 蒋荣江 LIU Wei;YU Chunzhao;YANG Jian;JIANG Rongjiang(Department of Urology,the Second Affiliated Hospital of Nanjing Medical University,Jiangsu Province,Nanjing210011,China;Department of General Surgery,the Second Affiliated Hospital of Nanjing Medical University,Jiangsu Province,Nanjing210011,China)
出处 《中国医药导报》 CAS 2022年第15期45-47,52,共4页 China Medical Herald
基金 政府间国际科技创新合作重点专项(2018YFE0127300)。
关键词 终末期肾病 获得性囊性肾病 肾细胞癌 研究进展 End-stage renal disease Acquired cystic kidney disease Renal cell carcinoma Research progress
  • 相关文献

参考文献4

二级参考文献26

  • 1Pan CC, Chen YJ, Chang LC, et al. Immunohistochemical and molecular genetic profiling of acquired cystic disease as sociated renal cell carcinoma. Histopathology, 2009, 55: 145- 53.
  • 2Dunnill MS, Millard PR,Oliver D. Acquired cysticdisease of the kidneys: a hazard o flong-term intermittent maintenance haemodialysis. J Clin Pathol, 1977, 30:868- 877.
  • 3Bommer J, Waldherr R, vanKaick G, et al. Acquired renal cysts in uremic patients in vivo demonstration by computed tomography. Clin Nephrol, 1980, 14: 299 -303.
  • 4Beardsworth SF, Goldsmith H J, Ahmad R,et al. Acquisition of renal cysts during pentoneal dialysis. Lancet, 1984, 2: 1482.
  • 5Peces R. Malignancy and chronic renal failure. Saudi J Kidney Dis Transpl, 2003,14:5 -14.
  • 6Ishikawa I, Saito Y, Asaka M, et al. Twenty year follow up of acquired renal cystic disease. Clin Nephrol, 2003, 59: 153 -159.
  • 7MatsonMA, Cohen EP. Acquired cystic kidney disease: oceurrence, prevalence, and renal cancers. Medicine, 1990, 69:217 -226.
  • 8Chandhoke PS, Torrence RJ, Clayman RV, et al. Acquired cystic disease of the kidney: a management dilemma. J Urol, 1992, 147: 969-974.
  • 9Levine E, Slusher SL, Grantham JJ, et al. Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinalct study. AJR,1991, 156:501 -506.
  • 10Hoshida Y, Nakanishi H, Shin M, et al. Renal neoplasias in patients receiving dialysis and renal transp: antation: clinieopathological features and P53 gene mutations. Transplantation,1999, 68: 385-390.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部